Nevan Krogan

Nevan Krogan is the Founder and President of Rezo Therapeutics since 2022 and has served as the Director of the Quantitative Biosciences Institute (QBI) at the University of California, San Francisco, where an academic career spans from Assistant Professor to Professor. Nevan Krogan is also a Senior Investigator at Gladstone Institutes and has previously held the position of Professor in Microbiology at the Icahn School of Medicine at Mount Sinai from 2019 to 2021. The academic background includes a PhD in Medical Genetics from the University of Toronto, a Master of Science in Biology from the University of Regina, and a Bachelor of Science in Biochemistry from the same institution.